Larotaxel dihydrate | MedChemExpress (MCE)
Larotaxel (dihydrate) (XRP9881 (dihydrate)), a new taxane compound prepared by partial synthesis from 10-deacetyl baccatin III, is active against tumors[1].
| Trivial name | Larotaxel dihydrate |
| Catalog Number | HY-125374A |
| Alternative Name(s) | XRP9881 dihydrate |
| Research Area | Cancer |
| CAS# | 192573-38-9 |
| Purity | ≥98.00% |
| SMILES | O=C([C@]1([H])OC(C)=O)[C@@]23[C@@]([C@@H]([C@@]4(O)C(C)(C)C1=C([C@H](OC([C@H](O)[C@H](C5=CC=CC=C5)NC(OC(C)(C)C)=O)=O)C4)C)OC(C6=CC=CC=C6)=O)([H])[C@]7([C@@](OC7)([H])C[C@@H]2C3)OC(C)=O.O.O |
| PubChem Chemical Structure ID | 6918259 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/larotaxel-dihydrate.html |